helvy.co.uk

Metabolic

Apolipoprotein B (ApoB)

In the UK, the standard clinical (NHS) reference range for Apolipoprotein B (ApoB) is <130 mg/dL, with <90 mg/dL (longevity-optimised: <80 mg/dL) considered the performance-optimised range. A result within these ranges suggests typical status; only a qualified clinician can interpret an individual reading.

Apolipoprotein B (ApoB) is the protein embedded in every atherogenic (artery-damaging) lipoprotein particle — including LDL, VLDL, IDL, and Lp(a). Unlike standard LDL cholesterol which measures the cholesterol content inside LDL particles, ApoB counts the actual number of particles. This distinction matters because particle number — not cholesterol content — drives atherosclerosis.

Last reviewed: 11 June 2026


Optimal Ranges

What is the optimal range for ApoB?

Clinical (NHS) Range

<130 mg/dL

mg/dL

Performance-Optimised Range

<90 mg/dL (longevity-optimised: <80 mg/dL)

mg/dL

Apolipoprotein B (ApoB) reference ranges (UK)
RangeValueUnit
Clinical (NHS) reference range<130 mg/dLmg/dL
Performance-optimised range<90 mg/dL (longevity-optimised: <80 mg/dL)mg/dL

The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best. A result in either range suggests typical status and is not a diagnosis; any individual reading should be interpreted by a qualified clinician.


Why It Matters

Why ApoB matters for performance

ApoB is increasingly recognised as the single best predictor of cardiovascular risk — superior to LDL-C, total cholesterol, and even the TC:HDL ratio. The European Atherosclerosis Society recommends ApoB measurement for accurate cardiovascular risk assessment. Two people can have identical LDL-C numbers but very different ApoB levels (and very different risk) depending on their particle size distribution. For men focused on longevity, ApoB is the marker that bridges the gap between a standard cholesterol panel and actual arterial risk.


Symptoms

What are the symptoms of low or high ApoB?

Low / Deficiency

  • Very low ApoB is generally not clinically significant
  • May indicate malabsorption or liver dysfunction in extreme cases

High / Excess

  • No direct symptoms — elevated ApoB is a silent risk factor
  • Associated with accelerated atherosclerosis
  • Increased risk of heart attack and stroke
  • Often accompanies metabolic syndrome and insulin resistance

Dietary Sources

Which foods support ApoB levels?

Reduce refined carbohydrates (drive small dense LDL particles)Increase soluble fibre — oats, legumes, psylliumOmega-3 rich fish (salmon, mackerel, sardines)Nuts — almonds and walnuts specifically shown to reduce ApoBReplace saturated fat with monounsaturated (olive oil, avocado)

Supplementation

How do you improve ApoB levels?

Omega-3 fish oil (2-4g EPA+DHA daily) reduces ApoB-containing particle count by lowering VLDL production. Plant sterols and stanols (2g/day) block cholesterol absorption and can reduce ApoB by 5-10%. Berberine (1,000-1,500mg daily in divided doses) has LDL-lowering effects comparable to low-dose statins in some studies — it upregulates LDL receptors. Citrus bergamot extract (500-1,000mg daily) has emerging evidence for LDL particle reduction. For significantly elevated ApoB (>130), lifestyle plus pharmaceutical intervention (statins) may be warranted — discuss with your GP.


Testing

How is ApoB tested in the UK?

ApoB is measured from a blood sample. With Helvy, that means a finger-prick kit taken at home and posted to a UKAS-accredited UK laboratory, with results in around 5 days, reviewed by a qualified clinician. Your result is reported against both the clinical range (<130 mg/dL) and the performance-optimal range (<90 mg/dL (longevity-optimised: <80 mg/dL)), so you can see not just whether you are “normal” but whether you are optimal. If you make a change, retest after 8-12 weeks to confirm it worked.


Research

Key study

Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target

Sniderman AD, Thanassoulis G, Glavinovic T, et al.

The Lancet (2019)

DOI: 10.1016/S0140-6736(19)32519-0

Related Biomarkers


Related Guides

Explore ApoB in depth


Test your ApoB levels

ApoB is included in the Helvy 50+ biomarker panel. Get your results in 5 days with a personalised protocol.

Order Your Test

This content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.